Within metabolic interaction networks, Gankyrin activates the β-catenin/c-Myc axis to upregulate PKM2 expression, strengthening the connection between glucose and glutamine metabolism and accelerating tumor progression (57). This evidence concerns the gene MYC and neoplasm.